DE69618015T2 - Cephalosporinantibiotika - Google Patents

Cephalosporinantibiotika

Info

Publication number
DE69618015T2
DE69618015T2 DE69618015T DE69618015T DE69618015T2 DE 69618015 T2 DE69618015 T2 DE 69618015T2 DE 69618015 T DE69618015 T DE 69618015T DE 69618015 T DE69618015 T DE 69618015T DE 69618015 T2 DE69618015 T2 DE 69618015T2
Authority
DE
Germany
Prior art keywords
cephalosporin antibiotics
cephalosporin
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69618015T
Other languages
English (en)
Other versions
DE69618015D1 (de
Inventor
In-Seop Cho
Scott Hecker
Tomasz Glinka
J Lee
J Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trine Pharmaceuticals Inc
Original Assignee
Microcide Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microcide Pharmaceuticals Inc filed Critical Microcide Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69618015D1 publication Critical patent/DE69618015D1/de
Publication of DE69618015T2 publication Critical patent/DE69618015T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE69618015T 1995-10-12 1996-10-11 Cephalosporinantibiotika Expired - Fee Related DE69618015T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US538995P 1995-10-12 1995-10-12
PCT/US1996/016349 WO1997013772A2 (en) 1995-10-12 1996-10-11 Cephalosporin antibiotics

Publications (2)

Publication Number Publication Date
DE69618015D1 DE69618015D1 (de) 2002-01-24
DE69618015T2 true DE69618015T2 (de) 2002-05-16

Family

ID=21715599

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69618015T Expired - Fee Related DE69618015T2 (de) 1995-10-12 1996-10-11 Cephalosporinantibiotika

Country Status (28)

Country Link
US (4) US6066630A (de)
EP (1) EP0874854B1 (de)
JP (1) JPH11513670A (de)
KR (2) KR100455544B1 (de)
CN (3) CN1183142C (de)
AR (1) AR005642A1 (de)
AT (1) ATE210666T1 (de)
AU (1) AU708676B2 (de)
BR (1) BR9611062A (de)
CA (1) CA2234255A1 (de)
CZ (1) CZ108998A3 (de)
DE (1) DE69618015T2 (de)
DK (1) DK0874854T3 (de)
ES (1) ES2164924T3 (de)
HK (3) HK1017887A1 (de)
HU (1) HUP9802545A3 (de)
IL (1) IL123983A (de)
MX (1) MX9802891A (de)
MY (1) MY127641A (de)
NO (1) NO323007B1 (de)
NZ (1) NZ321135A (de)
PL (1) PL192069B1 (de)
PT (1) PT874854E (de)
RO (1) RO119830B1 (de)
SK (1) SK283524B6 (de)
TW (1) TW474935B (de)
WO (1) WO1997013772A2 (de)
ZA (1) ZA968617B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1295935B1 (it) 1997-10-30 1999-05-28 Acs Dobfar Spa Derivati aminotiazolici utili nella preparazione di antibiotici b -lattamici
US6159706A (en) * 1997-12-23 2000-12-12 Newbiotics, Inc. Application of enzyme prodrugs as anti-infective agents
AR029004A1 (es) * 1999-09-22 2003-06-04 Essential Therapeutics Inc Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
US6723716B1 (en) * 1999-09-22 2004-04-20 Essential Therapeutics, Inc. 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
CN1439014A (zh) * 2000-07-07 2003-08-27 株式会社Lg生命科学 新型头孢菌素化合物及其制备方法
CA2409329A1 (en) * 2000-07-07 2002-01-17 Lg Life Sciences Ltd. Novel cephalosporin compounds and process for preparing the same
US6599893B2 (en) * 2000-08-29 2003-07-29 Essential Therapeutics, Inc. Cephalosporin antibiotics and prodrugs thereof
BR0114058A (pt) * 2000-09-21 2003-07-22 Essential Therapeutics Inc Pró-drogas de um antibiótico de ácido 7-acilamino-3heteroariltio-3-cefem carboxìlico
WO2002054743A2 (en) 2000-12-29 2002-07-11 Bellsouth Intellectual Property Corporation Web based messaging system with personalized caller specific messages
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
ES2314100T3 (es) 2001-05-03 2009-03-16 Monsanto Technology Llc Derivados de piruvato.
US6608196B2 (en) 2001-05-03 2003-08-19 Galileo Pharmaceuticals, Inc. Process for solid supported synthesis of pyruvate-derived compounds
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법
US7317001B2 (en) * 2002-06-06 2008-01-08 Oscient Pharmaceuticals Corporation Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20050043223A1 (en) * 2003-04-25 2005-02-24 Leach Timothy S. Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
KR20170124602A (ko) 2015-03-13 2017-11-10 포르마 세라퓨틱스 인크. Hdac8 억제제로서의 알파-신나미드 화합물 및 조성물
MA43811A (fr) 2016-03-07 2018-11-28 Merck Sharp & Dohme Composés d'arylmonobactame bicycliques et leurs méthodes d'utilisation pour le traitement des infections bactériennes
CN114671892B (zh) * 2022-04-24 2023-04-11 江苏海洋大学 含7-氨基头孢烷酸的1,3,4-噻二唑衍生物及制法与用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605997A5 (de) * 1974-08-30 1978-10-13 Ciba Geigy Ag
US3992377A (en) * 1974-12-13 1976-11-16 Eli Lilly And Company 3-Thio-substituted cephalosporin antibiotics
FR2457297A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
NO801501L (no) * 1979-05-23 1980-11-24 Rhone Poulenc Ind Fremgangsmaate for fremstilling av 3-tiovinylcefalosporiner
FR2494274A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
GR79043B (de) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
US5025006A (en) * 1990-06-26 1991-06-18 Merck & Co., Inc. 2-biphenyl-carbapenem antibacterial agents
US5077287A (en) * 1991-01-18 1991-12-31 Eli Lilly And Company 3-thiazolylthio carbacephem antibacterial agents
JPH05132488A (ja) * 1991-08-13 1993-05-28 Meiji Seika Kaisha Ltd 新規セフアロスポリン誘導体
TW427993B (en) * 1993-09-09 2001-04-01 Fujisawa Pharmaceutical Co New cephem compounds
US5789584A (en) * 1994-04-01 1998-08-04 Microcide Pharmaceuticals, Inc. Substituted-pyridinyl cephalosporin antibiotics active against methicillin resistant bacteria

Also Published As

Publication number Publication date
TW474935B (en) 2002-02-01
DE69618015D1 (de) 2002-01-24
NZ321135A (en) 2000-01-28
US6066630A (en) 2000-05-23
SK46498A3 (en) 1998-10-07
PL326150A1 (en) 1998-08-31
CN1179963C (zh) 2004-12-15
SK283524B6 (sk) 2003-09-11
CN1183142C (zh) 2005-01-05
CN1204336A (zh) 1999-01-06
NO981653L (no) 1998-06-11
RO119830B1 (ro) 2005-04-29
KR100491466B1 (ko) 2005-05-25
AR005642A1 (es) 1999-07-14
US6087355A (en) 2000-07-11
CN1291612A (zh) 2001-04-18
CA2234255A1 (en) 1997-04-17
IL123983A (en) 2007-03-08
US6057312A (en) 2000-05-02
KR100455544B1 (ko) 2005-01-15
ATE210666T1 (de) 2001-12-15
ZA968617B (en) 1997-10-21
AU708676B2 (en) 1999-08-12
CN1066735C (zh) 2001-06-06
NO323007B1 (no) 2006-12-18
WO1997013772A2 (en) 1997-04-17
HUP9802545A2 (hu) 1999-05-28
KR20040047794A (ko) 2004-06-05
BR9611062A (pt) 1999-07-13
HK1017887A1 (en) 1999-12-03
EP0874854B1 (de) 2001-12-12
PT874854E (pt) 2002-06-28
AU7441796A (en) 1997-04-30
HUP9802545A3 (en) 2001-01-29
MX9802891A (es) 1998-09-30
PL192069B1 (pl) 2006-08-31
CZ108998A3 (cs) 1998-07-15
NO981653D0 (no) 1998-04-08
EP0874854A2 (de) 1998-11-04
ES2164924T3 (es) 2002-03-01
HK1034191A1 (en) 2001-10-19
CN1291611A (zh) 2001-04-18
JPH11513670A (ja) 1999-11-24
KR19990064201A (ko) 1999-07-26
HK1034248A1 (en) 2001-10-19
MY127641A (en) 2006-12-29
US5859256A (en) 1999-01-12
DK0874854T3 (da) 2002-03-25
WO1997013772A3 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
NO964139D0 (no) Cefalosporinantibiotika
FI930474A0 (fi) Antibiotiska foereningar
DE69618015T2 (de) Cephalosporinantibiotika
BR9608517A (pt) Cefalosporinas antibacterianas
NO974536D0 (no) Ascomyciner
NO963805D0 (no) Cefalosporinderivater
EP0727426A3 (de) Cephalosporinderivate
NO992526D0 (no) Cephalosporin-derivater
AU5985596A (en) Cephalosporin antibiotics
DK0949262T3 (da) Cephemforbindelser
KR960013362A (ko) 항균제
NO952527D0 (no) Antibiotika
NO982879D0 (no) Vannl°selige antibiotika
BR9603734A (pt) Derivados de cefalosporina
LT96154A (en) Cephalosporin antibiotics
FI971952A0 (fi) Antibiotiskt aemne
NO920017D0 (no) Cefalosporinderivater
NO934078D0 (no) Cefalosporinderivater
ITMI941228A0 (it) Nuove cefalosporine
BR7500758U (pt) Calceiro basculante

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ESSENTIAL THERAPEUTICS,INC., MOUNTAINVIEW, CALIF.,

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee